Physical Sciences and Mathematics Commons^™

Two-Electron Donating Phenothiazines And Use Thereof, Susan A. Odom, Aman Preet Kaur, Matthew D. Casselman, Nuwan Harsha Attanayake

Chemistry Faculty Patents

Compounds for use as electrolyte in a non-aqueous redox battery are provided, including an N-substituted phenothiazine compound according to the formula: (see patent for formula.)

R' is alkyl and R is selected from alkyl, aryl, alkylaryl, alkoxyaryl, alkylcarboxyl, arylcarbonyl, haloalkyl, perfluo- roalkyl, glycol, polyether, haloaryl, a negative electrolyte, a polymerizable unit, and a polymer.

Rechargeable Batteries Including High-Voltage Cathode And Redox Shuttle Conferring Overcharge Protection, Susan A. Odom, Aman Preet Kaur, Corrine F. Elliott

Chemistry Faculty Patents

Compounds for use as photoredox catalysts and as redox shuttles in a rechargeable battery having a high-voltage cathode providing overcharge protection capabilities are provided, including a compound according to the formula: (see patent for formula)

wherein R is selected from the group consisting of alkyl, aryl, alkylaryl, alkoxyaryl, alkylcarboxyl, aryl carbonyl, haloalkyl, perfluoroalkyl, glycols, haloaryl, a negative electrolyte, and a polymer.

1,9,10-Substituted Phenothiazine Derivatives With Strained Radical Cations And Use Thereof, Susan A. Odom, Chad Risko, Matthew D. Casselman, Corrine F. Elliott, Nuwan Harsha Attanayake, Subrahmanyam Modekrutti

Chemistry Faculty Patents

Compounds for use in a rechargeable battery are provided, including a compound according to the formula: (see patent for the formula)

wherein R₁ and R₉ are independently selected from the group consisting of H, alkyl, aryl, perfluoroaryl, perfluoroalkyl, alkylaryl, alkoxyaryl, alkylcarboxyl, aryl carbonyl, haloalkyl, perfluoroalkyl, glycols, haloaryl, a negative electrolyte, and a polymer, so long as when R₁ is H, R₉ is not H; and R₁₀ is selected from the group consisting of methyl, alkyl, aryl, alkylaryl, alkoxyaryl, alkylcarboxyl, aryl carbonyl, haloalkyl, perfluoroalkyl, perfluoroaryl, glycols, haloaryl, an oligomer, and a polymer.

Zirconia-Based Compositions For Use In Passive NoX Adsorber Devices, Deborah Jayne Harris, David Alastair Scapens, John G. Darab, Mark Crocker, Yaying Ji

Chemistry Faculty Patents

A passive NO_x adsorbent includes: palladium, platinum or a mixture thereof and a mixed or composite oxide including the following elements in percentage by weight, expressed in terms of oxide: 10-90% by weight zirconium and 0.1-50% by weight of least one of the following: a transition metal or a lanthanide series element other than Ce.

Although the passive NO_x adsorbent can include Ce in an amount ranging from 0.1 to 20% by weight expressed in terms of oxide, advantages are obtained particularly in the case of low-Ce or a substantially Ce-free passive NO_x adsorbent.

Synthesis Of Metal Oxide Surfaces And Interfaces With Crystallographic Control Using Solid-Liquid-Vapor Etching And Vapor-Liquid-Solid Growth, Beth S. Guiton, Lei Yu

Chemistry Faculty Patents

The present invention provides integrated nanostructures comprising a single-crystalline matrix of a material A containing aligned, single-crystalline nanowires of a material B, with well-defined crystallographic interfaces are disclosed. The nanocomposite is fabricated by utilizing metal nanodroplets in two subsequent catalytic steps: solid-liquid-vapor etching, followed by vapor-liquid-solid growth. The first etching step produces pores, or “negative nanowires” within a single-crystalline matrix, which share a unique crystallographic direction, and are therefore aligned with respect to one another. Further, since they are contained within a single, crystalline, matrix, their size and spacing can be controlled by their interacting strain fields, and the array …

Non-Aqueous Redox Flow Batteries Including 3,7-Perfluoroalkylated Phenothiazine Derivatives, Susan A. Odom, Aman Preet Kaur, Corrine F. Elliott, Matthew D. Casselman

Chemistry Faculty Patents

A non-aqueous redox flow battery includes a negative electrode immersed in a first non-aqueous liquid electrolyte solution, a positive electrode immersed in a second nonaqueous liquid electrolyte solution, and a semi-permeable separator interposed between the negative and positive electrodes, wherein the second the non-aqueous liquid electrolyte solution comprises a compound of the formula...

To see the remainder of this abstract, please download this patent.

Liquid Phenothiazine Catholytes For Non-Aqueous Redox Flow Batteries, Susan A. Odom, Matthew D. Casselman, Aman Preet Kaur

Chemistry Faculty Patents

Highly soluble, liquid phenothiazines containing methoxy-terminated ether and oligoether substituents are disclosed with high diffusion coefficients and robust performance in electrochemical measurements, which can be synthesized in one step from commercially-available starting materials, thereby circumventing previous synthetic limitations.

Treatment Of Mci And Alzheimer's Disease, Mark A. Lovell, Bert C. Lynn

Chemistry Faculty Patents

The present invention provides, among other things, therapeutic compositions and methods that can effectively treat, slow or prevent a neurological disease (e.g., a neurodegenerative disease, e.g., mild cognitive impairment (MCI) or Alzheimer's disease (AD)), in particular, based on therapeutically effective amount of nifedipine, oxidized or nitroso nifedipine derivatives, lactam (e.g., a compound of formula (Ic) or (Ic-i), e.g., NFD-L1), thyroxine (T4), triiodothyronine (T3) and combinations thereof.

Process For Detection Of Alzheimer's Disease From A Serum Sample, Mark A. Lovell, Bert C. Lynn

Chemistry Faculty Patents

Disclosed is a method of detecting a concentration of a biomarker in a human subject having or being at risk of developing Alzheimer's disease or Mild Cognitive Impairment (MCI). Also disclosed is a process for detecting a concentration of a biomarker in a human subject having or being at risk of developing Alzheimer's disease or Mild Cognitive Impairment (MCI) comprising (a) detecting a first concentration of lipocalin-PDS/TTR complex in a blood sample or urine sample from the subject, (b) determining a second concentration of PDS/TTR complex in a blood sample or urine sample from an unaffected individual, and ( c) …

Light-Activated Compounds, Edith C. Glazer, David K. Heidary

Chemistry Faculty Patents

The presently-disclosed subject matter includes light-activated ruthenium compounds. In some embodiments the compounds release one or more ligands when exposed to light, and in specific embodiments the light includes a wavelength of about 500 nm to about 1000 nm. The present compounds can also comprise an overall charge, wherein the overall charge can be a positive overall charge or a negative overall charge. Further still, embodiments include methods of treating cancer in a subject by administering a compound and then exposing a site of the subject to light.

Semiconducting Compounds And Devices Incorporating Same, Mark D. Watson

Chemistry Faculty Patents

Disclosed are semiconducting compounds having one or more phthalimide units and/or one or more head-to-head (H-H) substituted biheteroaryl units. Such compounds can be monomeric, oligomeric, or polymeric, and can exhibit desirable electronic properties and possess processing advantages including solution−processability and/or good stability at ambient conditions.

Low Voltage Electrowetting Device And Method For Making Same, Yuguang Cai, Xiaoning Zhang

Chemistry Faculty Patents

An electrowetting device includes a substrate having a first face, a charged adhesion layer immobilized on the first face of the substrate and a dielectric layer bound to the charged adhesion layer. An unbound ionic liquid phase contacts the dielectric layer.

Systems And Methods For Diagnosis And Monitoring Of Bacteria-Related Conditions, Sylvia Daunert, Sapna K. Deo, Patrizia Pacini, Anjali Kumari Struss, Harohalli Shashidhar, Deborah R. Auer Flomenhoft, Nilesh Raut

Chemistry Faculty Patents

The presently-disclosed subject matter provides systems, methods, and kits for diagnosing and/or monitoring a bacteria-related condition of interest in a subject by providing a cell sensing system, each system containing a reporter molecule capable of detecting binding of a quorum sensing molecule and capable of generating a detectable signal.

Thiol-Containing Compounds For The Removal Of Elements From Tissues And Formulations Therefor, Boyd E. Haley, David A. Atwood, Niladri Gupta

Chemistry Faculty Patents

Methods and pharmaceutical formulations for ameliorating heavy metal toxicity and/or oxidative stress are disclosed, comprising administering pharmaceutically effective amounts of ligands according to the present disclosure.

To see the remainder of the abstract, please download this patent.

Polypeptides, Systems, And Methods Useful For Detecting Glucose, Sylvia Daunert, Kendrick Turner, Smita Joel, Laura Rowe

Chemistry Faculty Patents

The presently-disclosed subject matter provides biosensors for detecting molecules of interest. The biosensors include a polypeptide capable of selectively-binding glucose, wherein the polypeptide molecule is selected from: an unnatural analogue of wild type glucose binding protein; a fragment of wild type glucose binding protein; and an unnatural analogue fragment of wild type glucose binding protein.

Method Of Ameliorating Oxidative Stress And Supplementing The Diet, Boyd E. Haley, Niladrl Narayan Gupta

Chemistry Faculty Patents

A method of supplementing a diet and ameliorating oxidative stress in a mammal includes administering a pharmaceutically effective amount of lipid soluble, hydrophobic active compounds having a chemical structure . . .

To see the remainder of this abstract, please download this patent.

Methods And Compositions For Treating Neurological Disorders, Tae H. Ji, Inhae Ji

Chemistry Faculty Patents

This disclosure relates to methods and compositions useful for the treatment of senile dementia. More particularly the disclosure relates to methods and compositions for the treatment of senile dementia related to diabetes.

Biomarkers Of Mild Cognitive Impairment And Alzheimer's Disease, Mark A. Lovell, Bert C. Lynn

Chemistry Faculty Patents

A method for quantifying a neurodegenerative disorder in a patient that includes obtaining a fluid sample from the subject; measuring a protein biomarker complex in said fluid sample and correlating the measurement with mild cognitive impairment or Alzheimer's disease status. The biomarkers include those that comprise at least one of a transthyretin protein and/or a prostaglandin-H2 D-isomerase protein, and at least one second, different protein selected from a transthyretin, prostaglandin-H2 D-isomerase, beta-2-microglobulin, cystatin C, superoxide dismutase [Cu—Zn], plasma retinol-binding protein, phosphatidylethanolamine-binding protein, carbonic anhydrase 2, prostaglandin-H2 D-isomerase, and/or serotransferrin protein.

Precatalysts Useful In Polyolefin Polymerization Reactions, Omofolami Tesileem Ladipo, Richard Eaves, Alexey Zazybin, Sean Parkin

Chemistry Faculty Patents

Compounds are provided that are useful as precatlysts in the polymerization of olefins such as ethylene and propylene. Other compounds are useful as intermediates in the production of such precatalysts.

Trans-Excision-Splicing Ribozyme And Methods Of Use, Stephen M. Testa, Michael A. Bell

Chemistry Faculty Patents

A group I intron-derived ribozyme which binds RNA in trans, excises an internal segment from within the RNA, and splices the remaining 5′ and 3′ ends of the RNA back together (the trans-excision-splicing reaction) is disclosed. The excised segment can be as long as 28 nucleotides, or more, and as little as one nucleotide. The ribozymes of the invention are easily modified to alter their sequence specificity. Such ribozymes represent a new and potentially powerful class of generally adaptable genetic therapeutics.

Methods And Kit For Determination Of Prostacyclin In Plasma, Sylvia Daunert, Michael Poon, Urvee Desai, Sapna K. Deo

Chemistry Faculty Patents

A solid-phase immunoassay for 6-keto-Prostaglandin F_1α, the stable hydrolysis product of prostacyclin (Prostaglandin I₂) is disclosed. Prostacyclin, a potent vasodilator with anti-platelet and anti-proliferative properties is an effective treatment for primary pulmonary hypertension and pulmonary arterial hypertension associated with scleroderma and scleroderma-like syndrome. Levels of 6-keto-Prostaglandin F_1α can be directly correlated with levels of prostacyclin. Therefore, 6-keto-Prostaglandin F_1α has become the indicator of choice to measure prostacyclin levels. The single step immunoassay for 6-keto-Prostaglandin F_1α uses the bioluminescent protein, aequorin as a label. Analyte-label conjugates were constructed by linking the carboxyl group of …

Stimuli-Responsive Hydrogel Microdomes Integrated With Genetically Engineered Proteins For High-Throughput Screening Of Pharmaceuticals, Sylvia Daunert, Sapna K. Deo, Jason Douglas Ehrick, Tyler William Browning, Leonidas G. Bachas

Chemistry Faculty Patents

A hydrogel microdome that can swell in response to a stimuli or target molecule is formed by polymerizing a mixture comprising a monomer capable of forming a hydrogel with a biopolymer. An array of hydrogel microdomes can be formed on a substrate by microspotting the mixture and polymerizing. The array can be used for high-throughput screening of analytes as well as for use as an actuator and biosensor using the swelling property of the hydrogel.

Use Of Boron Compounds To Precipitate Uranium From Water, David A. Atwood

Chemistry Faculty Patents

A method is provided for removing uranium from water. The method includes the mixing of a boron reagent with water contaminated with uranyl dication ions, leading to removal of the uranium from that water.

Silylethynylated Heteroacenes And Electronic Devices Made Therewith, John E. Anthony, Marcia M. Payne, Susan A. Odom, Sean Parkin

Chemistry Faculty Patents

Novel silylethynylated heteroacenes and electronic devices made with those compounds are disclosed.

Aequorin And Obelin Mutants With Differing Wavelengths And Bioluminescence, Sylvia Daunert, Sapna K. Deo, Emre Dikici, Laura Rowe

Chemistry Faculty Patents

The invention relates to aequorin and obelin mutants whose emission is shifted with respect to wild type. The shift in emission is accomplished using a combination of mutations of amino acids within aequorin or obelin that affect bioluminescence; use of different types of chromophores, i.e., coelenterazines with variable emission characteristics; and modifications of the photoprotein with fluorophores that will allow for emission of light at longer wavelengths as a result of energy transfer. Additionally, an assay employing aequorin mutants to test for HIV-1 protease inhibitors is disclosed.

Trans-Excision-Splicing Ribozyme And Methods Of Use, Stephen M. Testa, Michael A. Bell

Chemistry Faculty Patents

A group I intron-derived ribozyme which binds RNA in trans, excises an internal segment from within the RNA, and splices the remaining 5′ and 3′ ends of the RNA back together (the trans-excision-splicing reaction) is disclosed. The excised segment can be as long as 28 nucleotides, or more, and as little as one nucleotide. The ribozymes of the invention are easily modified to alter their sequence specificity. Such ribozymes represent a new and potentially powerful class of generally adaptable genetic therapeutics.

Catalytic Cleavage Of Phosphate Ester Bonds By Boron Chelates, David A. Atwood

Chemistry Faculty Patents

Novel chemical compounds are disclosed having the general formula L{YX_m}_n, wherein X is selected from the Group 13 elements, Y is a halide, and L is a chelating ligand containing at least one binding atom contacting the Group 13 element, the atom being selected from the group consisting of C, N, O, and S, and m and n are integers having a value of at least 1. L may be a Schiff base type ligand, such as a salen ligand. The compositions of the present invention may be bidentate, quadridentate, or greater. The compositions may be …

Cleavage Of Phosphate Ester Bonds By Use Of Novel Group 13 Chelate Compounds, David A. Atwood

Chemistry Faculty Patents

A novel chemical compound has a general formula (LX)_nY wherein X is selected from a group consisting of a group 13 element other than boron, Y is selected from a group consisting of a halide, a chlorate, a sulfate and a nitrate and L is a chelating ligand containing two nitrogen and two oxygen donor groups where n=1 or 2.

Method For Prevention Of Solid Dissolution Through Covalent Ligand Bonding, David A. Atwood

Chemistry Faculty Patents

Methods for preventing dissolution of solid substrates, such as metal leaching from coal or corrosion of metal surfaces, are provided.

To read the remainder of this abstract, please download this patent.

Substituted Pentacenes And Electronic Devices Made With Substituted Pentacenes, John E. Anthony, David L. Eaton, Sean Parkin

Chemistry Faculty Patents

Novel substituted pentacenes and electronic devices made with those substituted pentacenes are disclosed.